CD4 and lymphopenia: The preservation of these age and naïve CD4+ T cell level relationships in the SVR group indicated that DAA treatment may interrupt only the HCV-mediated mechanisms, but not the age-related mechanisms, of naïve CD4+ lymphopenia and therefore provide a possible explanation why naïve CD4+ lymphopenia was not completely normalized in our older HCV-infected cohort on DAA therapy.